Matthias Krieger is the founder of FinVector. Backed by Ferring Ventures S/A. Based in Kuopio, Finland.
Matthias Krieger is the Managing Director of FinVector Oy, effective April 22nd, 2023. FinVector is a gene therapy company focused on bringing breakthrough gene therapies to market, including Adstiladrin®. Prior to joining FinVector, Krieger spent over 20 years in the pharmaceutical industry, primarily with Novartis, holding various leadership roles in Switzerland and the United States. He has a background in R&D and manufacturing, crucial for product launch and commercialization.
Full founder directory · Investor directory · Company funding database · Fundraising library